101 related articles for article (PubMed ID: 28539956)
21. Metabolic Effects of Antidepressant Treatment.
Olguner Eker Ö; Özsoy S; Eker B; Doğan H
Noro Psikiyatr Ars; 2017 Mar; 54(1):49-56. PubMed ID: 28566959
[TBL] [Abstract][Full Text] [Related]
22. Advances in the management of diabetic neuropathy.
Várkonyi T; Körei A; Putz Z; Martos T; Keresztes K; Lengyel C; Nyiraty S; Stirban A; Jermendy G; Kempler P
Minerva Med; 2017 Oct; 108(5):419-437. PubMed ID: 28541026
[TBL] [Abstract][Full Text] [Related]
23. Escitalopram or novel herbal treatments differentially alter cytokine and behavioral responses to immune challenge.
Avitsur R; Paley S; Franko M; Wolff N; Eyal N; Doron R
J Neuroimmunol; 2017 Aug; 309():111-118. PubMed ID: 28601279
[TBL] [Abstract][Full Text] [Related]
24. Characterizing Highly Benefited Patients in Randomized Clinical Trials.
Charu V; Rosenberg PB; Schneider LS; Drye LT; Rein L; Shade D; Lyketsos CG; Frangakis CE
Int J Biostat; 2017 May; 13(1):. PubMed ID: 28541924
[TBL] [Abstract][Full Text] [Related]
25. Reduced serum VGF levels were reversed by antidepressant treatment in depressed patients.
Jiang H; Chen S; Lu N; Yue Y; Yin Y; Zhang Y; Jiang W; Liang J; Yuan Y
World J Biol Psychiatry; 2017 Dec; 18(8):586-591. PubMed ID: 28635540
[TBL] [Abstract][Full Text] [Related]
26. Impact of etiology and duration of pain on pharmacological treatment effects in painful polyneuropathy.
Sindrup SH; Holbech J; Demant D; Finnerup NB; Bach FW; Jensen TS
Eur J Pain; 2017 Sep; 21(8):1443-1450. PubMed ID: 28557178
[TBL] [Abstract][Full Text] [Related]
27. Correlation between cytochrome P450 2C19 genetic polymorphism and treatment response to escitalopram in panic disorder.
He Q; Yuan Z; Liu Y; Zhang J; Yan H; Shen L; Luo X; Zhang Y
Pharmacogenet Genomics; 2017 Aug; 27(8):279-284. PubMed ID: 28614176
[TBL] [Abstract][Full Text] [Related]
28. Repeated co-treatment with antidepressants and risperidone increases BDNF mRNA and protein levels in rats.
Rogóż Z; Kamińska K; Pańczyszyn-Trzewik P; Sowa-Kućma M
Pharmacol Rep; 2017 Oct; 69(5):885-893. PubMed ID: 28624596
[TBL] [Abstract][Full Text] [Related]
29. Serotonergic 5HTTLPR/rs25531 s-allele homozygosity associates with violent suicides in male citalopram users.
Rahikainen AL; Majaharju S; Haukka J; Palo JU; Sajantila A
Am J Med Genet B Neuropsychiatr Genet; 2017 Oct; 174(7):691-700. PubMed ID: 28608626
[TBL] [Abstract][Full Text] [Related]
30. Chlorpheniramine and escitalopram: Similar antidepressant and nitric oxide lowering roles in a mouse model of anxiety.
Gammoh O; Mayyas F; Darwish Elhajji F
Biomed Rep; 2017 Jun; 6(6):675-680. PubMed ID: 28584640
[TBL] [Abstract][Full Text] [Related]
31. Stable Remission of Multiple Chemical Sensitivity Syndrome and Major Depression With Citalopram and 1-Month Deep Transcranial Magnetic Stimulation: A Case Report.
Del Casale A; Rapinesi C; Kotzalidis GD; Sorice S; Padovano A; Gentile G; Angeletti G; Ferracuti S; Sani G; Pompili M; Simmaco M; Girardi P
J ECT; 2017 Sep; 33(3):e27-e29. PubMed ID: 28570499
[No Abstract] [Full Text] [Related]
32. Statin and Its Association With Delirium in the Medical ICU.
Mather JF; Corradi JP; Waszynski C; Noyes A; Duan Y; Grady J; Dicks R
Crit Care Med; 2017 Sep; 45(9):1515-1522. PubMed ID: 28622167
[TBL] [Abstract][Full Text] [Related]
33. Pregabalin and heart failure: A population-based study.
Ho JM; Macdonald EM; Luo J; Gomes T; Antoniou T; Mamdani MM; Juurlink DN
Pharmacoepidemiol Drug Saf; 2017 Sep; 26(9):1087-1092. PubMed ID: 28620909
[TBL] [Abstract][Full Text] [Related]
34. Association of Cognitive Impairment in Patients on 3-Hydroxy-3-Methyl-Glutaryl-CoA Reductase Inhibitors.
Roy S; Weinstock JL; Ishino AS; Benites JF; Pop SR; Perez CD; Gumbs EA; Rosenbaum JA; Roccato MK; Shah H; Contino G; Hunter K
J Clin Med Res; 2017 Jul; 9(7):638-649. PubMed ID: 28611866
[TBL] [Abstract][Full Text] [Related]
35. Quetiapine extended release versus aripiprazole in children and adolescents with first-episode psychosis: the multicentre, double-blind, randomised tolerability and efficacy of antipsychotics (TEA) trial.
Pagsberg AK; Jeppesen P; Klauber DG; Jensen KG; Rudå D; Stentebjerg-Olesen M; Jantzen P; Rasmussen S; Saldeen EA; Lauritsen MG; Bilenberg N; Stenstrøm AD; Nyvang L; Madsen S; Werge TM; Lange T; Gluud C; Skoog M; Winkel P; Jepsen JRM; Fagerlund B; Correll CU; Fink-Jensen A
Lancet Psychiatry; 2017 Aug; 4(8):605-618. PubMed ID: 28599949
[TBL] [Abstract][Full Text] [Related]
36. Predictors of treatment response and drop out in the Treatment of Early-Onset Schizophrenia Spectrum Disorders (TEOSS) study.
Gabriel D; Jakubovski E; Taylor JH; Artukoglu BB; Bloch MH
Psychiatry Res; 2017 Sep; 255():248-255. PubMed ID: 28595147
[TBL] [Abstract][Full Text] [Related]
37. Adverse Events With Sustained-Release Donepezil in Alzheimer Disease: Relation to Body Mass Index.
Lee C; Lee K; Yu H; Ryu SH; Moon SW; Han C; Lee JY; Lee YM; Kim SG; Kim KW; Lee DW; Kim SY; Lee SY; Bae JN; Jung YE; Kim JL; Kim BS; Shin IS; Kim YH; Kim BJ; Kang HS; Myung W; Carroll BJ; Kim DK
J Clin Psychopharmacol; 2017 Aug; 37(4):401-404. PubMed ID: 28590369
[TBL] [Abstract][Full Text] [Related]
38. Opioid analgesics-related pharmacokinetic drug interactions: from the perspectives of evidence based on randomized controlled trials and clinical risk management.
Feng XQ; Zhu LL; Zhou Q
J Pain Res; 2017; 10():1225-1239. PubMed ID: 28579821
[TBL] [Abstract][Full Text] [Related]
39. Oral glucose tolerance test performance in olanzapine-treated schizophrenia-spectrum patients is predicted by BMI and triglycerides but not olanzapine dose or duration.
Guina J; Roy S; Gupta A; Langleben DD; Elman I
Hum Psychopharmacol; 2017 Jul; 32(4):. PubMed ID: 28573760
[TBL] [Abstract][Full Text] [Related]
40. Incidence and risk factors of acute akathisia in 493 individuals with first episode non-affective psychosis: a 6-week randomised study of antipsychotic treatment.
Juncal-Ruiz M; Ramirez-Bonilla M; Gomez-Arnau J; Ortiz-Garcia de la Foz V; Suarez-Pinilla P; Martinez-Garcia O; Neergaard KD; Tabares-Seisdedos R; Crespo-Facorro B
Psychopharmacology (Berl); 2017 Sep; 234(17):2563-2570. PubMed ID: 28567698
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]